Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Professor Nancy Ip discusses her groundbreaking neuroscience research, focusing on neurotrophic factors and innovative Alzheimer’s disease treatment approaches.

T2D Remission Buffers; Another Sotagliflozin Trial; More Gender-Affirming Care Bans?

People with any evidence of type 2 diabetes remission with diet and lifestyle changes had a 40% lower rate of cardiovascular disease and a 33%

January 24, 2024

CDC: Cases of MIS-C After COVID Still Occurring in U.S. Kids

Cases of multisystem inflammatory syndrome in children (MIS-C) are still popping up, but at lower rates than those observed early in the COVID-19 pandemic, CDC

March 16, 2024

Maternal diabetes linked to a slight increase in ADHD risk in children

Large-scale study reveals that maternal diabetes mellitus is associated with a slightly increased risk of ADHD in offspring, highlighting the complex interplay of genetic and

April 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.